How to Buy Dr Reddys Laboratories Stock
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories is a pharmaceutical company located in India, which is part of the Healthcare sector, and is traded under the ticker RDY on the NYSE exchange.
Dr Reddys Laboratories stock last closed at $71.14, up 0.32% from the previous day, and has increased 18% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.3 percentage points. Dr Reddys Laboratories stock is currently +33.92% from its 52-week low of $53.12, and -8.47% from its 52-week high of $77.72.
At the moment, there are 166.53M RDY shares outstanding. The market value of RDY is $11.85B. In the last 24 hours, 116,990 RDY shares were traded.
How to Buy Dr Reddys Laboratories Stock
Not sure how to invest in Dr Reddys Laboratories stock? Here's how.
- Choose where to buy Dr Reddys Laboratories stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you choose where to buy Dr Reddys Laboratories stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit funds into your brokerage account: Pick your payment method and add your info.
- Analyze Dr Reddys Laboratories stock: The Dr Reddys Laboratories ticker symbol is RDY. Is Dr Reddys Laboratories stock a good investment? Should you buy shares of RDY? How do RDY's underlying business fundamentals look? Do top analysts think Dr Reddys Laboratories is a good buy? Why has RDY's stock price moved recently? (Hint: Our stock market research website can help you figure out if RDY is a good stock to buy).
- Make your RDY purchase: Decide if you will purchase RDY shares at the current market price or use a limit order to buy RDY stock at a particular price.
- Track your investment in RDY: Create a watchlist to watch your investment in Dr Reddys Laboratories shares.
Step 1: Choose where to buy Dr Reddys Laboratories stock
You will need an online brokerage account to access the NYSE market and buy RDY shares.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Industrials, New York to London — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by opening an account with eToro now.
Open eToro AccountStep 2: Open your brokerage account
Now that you've picked the best brokerage, it's time to fill out some personal info so you can invest in RDY stock today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to create your new brokerage account.
- Submit your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've created your account on stock market app, you need to deposit funds:
Check out the tutorial below for more details transferring money into your brokerage account.
Step 4: Analyze Dr Reddys Laboratories stock
After you have figured out the best place to buy Dr Reddys Laboratories stock, it's absolutely critical to research their stock before you invest, so you truly comprehend the risk and opportunity.
Dr Reddys Laboratories Numbers
Fundamentals of RDY
WallStreetZen was built to help average investors perform better fundamental analysis quickly.
You can see all of the due diligence checks on RDY's stock page.
How is RDY stock valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge RDY's intrinsic value.
Using relative valuations ratios:
- RDY could be overvalued based on its P/B ratio of 4.22x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.03x
You can access more valuation analysis on RDY's stock here.
How do RDY Financials look?
Passed Financial Due Diligence Checks:
- RDY earnings of $751.03M is not sufficient to cover its interest payments.
- Total RDY debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the RDY balance sheet.
- RDY profit margin has gone up from 11% to 18.3% in the past year.
- RDY's operating cash flow of $845.76M allows it to safely service it's debt of $163.73M.
- RDY has a low debt to equity ratio of 0.39.
- There are more short-term assets than short-term liabilities on the RDY balance sheet.
Do Wall Street analysts think it's a good time to buy Dr Reddys Laboratories stock
Out of 1 Wall Street analysts who give ratings on RDY, the consensus analyst rating on RDY is a Strong Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are forecasting on the Dr Reddys Laboratories stock forecast page.
RDY Technical Indicators
Is RDY Growing Revenue?
Last year, RDY revenue was $2.99B. During the past five year, RDY's revenue has gone up by 6.52% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 30.96%.
Dig into RDY's earnings and revenue performance here.
What are RDY executives and large shareholders up to?
In the last 12 months, insiders at RDY have not bought or sold any shares.
Learn more about who owns RDY stock here.
Can I rely on RDY as an income stream?
Dr Reddys Laboratories pays a dividend of 1.37%, compared to the Drug Manufacturers - Specialty & Generic industry's average dividend yield of 3.68%. If you owned $1,000 worth of RDY stock, you would have been paid $13.71 in the past 12 months.
Dr Reddys Laboratories dividend payments have consistently grown over the past decade and have remained stable.
Dig into more analysis about Dr Reddys Laboratories dividend yield and history here.
RDY Social Trading Data
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your RDY purchase
You have two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are usually sufficient. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a particular dollar amount limit, place a limit order.
Hit the Open button and your broker will execute the order.
If you require more help with buying stocks on eToro, click the how to video below:
Step 6: Track your investment in RDY
Now that you own some RDY shares, you'll want to stay up-to-date on your shares.
Start a watchlist to get alerted to the latest events about your RDY stock.
RDY Feed
How to Buy Stock in Dr Reddys Laboratories
To reiterate, here are the 6 steps for buying Dr Reddys Laboratories stock:
- Choose where to buy Dr Reddys Laboratories stock
- Open your brokerage account
- Deposit funds into your brokerage account
- Analyze Dr Reddys Laboratories stock
- Make your RDY purchase
- Track your investment in RDY
If you are looking for a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get the latest news on your new investment in Dr Reddys Laboratories, hit the button below to create your watchlist.
Trending Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.